{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:20:09Z","timestamp":1790281209714,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Soenderborg Hospital Research Fund"},{"name":"Vejle Hospital Research Fund"},{"name":"The Danish Foundation for Neurological Research"},{"name":"The Ole Jacobsen Commemoration Fund"},{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jneuroim.2012.09.010","type":"journal-article","created":{"date-parts":[[2012,9,29]],"date-time":"2012-09-29T20:02:46Z","timestamp":1348948966000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid"],"prefix":"10.1016","volume":"254","author":[{"given":"Nasrin","family":"Asgari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khorooshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren T.","family":"Lillevang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.09.010_bb0005","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain","volume":"4","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0404.2010.01416.x","article-title":"Neuromyelitis optica (NMO) \u2014 an autoimmune disease of the central nervous system (CNS)","volume":"123","author":"Asgari","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb9000","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1352458511417480","article-title":"HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica","volume":"18","author":"Asgari","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/10454411950060020301","article-title":"Complement biosynthesis in the central nervous system","volume":"6","author":"Barnum","year":"1995","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0035","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","article-title":"Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"103","author":"Bernal","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0040","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0050","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0055","first-page":"279","article-title":"Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors","volume":"215","author":"Furlan","year":"2003","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00429-005-0067-8","article-title":"Heterogeneous occurrence of aquaporin-4 in the ependyma and in the circumventricular organs in rat and chicken","volume":"211","author":"Goren","year":"2006","journal-title":"Anat. Embryol. (Berl)"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1073\/pnas.1109980108","article-title":"Molecular outcomes of neuromyelitis optica (NMO)\u2010IgG binding to aquaporin-4 in astrocytes","volume":"109","author":"Hinson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/glia.1111","article-title":"T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"36","author":"Iglesias","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-7-52","article-title":"Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance","volume":"7","author":"Jarius","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI101335","article-title":"An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins","volume":"21","author":"Kabat","year":"1942","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0085","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4049\/jimmunol.0901753","article-title":"Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system","volume":"185","author":"Khorooshi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0095","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-5728(87)90031-2","article-title":"Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin\/oligodendrocyte glycoprotein (MOG)","volume":"17","author":"Linington","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0105","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0110","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.4049\/jimmunol.178.12.8175","article-title":"IFN-gamma-induced chemokines synergize with pertussis toxin to promote T cell entry to the central nervous system","volume":"178","author":"Millward","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: from molecules to medicine","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuroscience.2004.03.016","article-title":"Expression of aquaporin water channels in mouse spinal cord","volume":"127","author":"Oshio","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0125","doi-asserted-by":"crossref","first-page":"e27412","DOI":"10.1371\/journal.pone.0027412","article-title":"Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema","volume":"6","author":"Ratelade","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0130","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2011.03.007","article-title":"T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement","volume":"235","author":"Saadoun","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0145","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.139.12.4016","article-title":"A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease","volume":"139","author":"Schluesener","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0150","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0155","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.4049\/jimmunol.164.5.2759","article-title":"IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines","volume":"164","author":"Tran","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1155\/2006\/586306","article-title":"NMO-IgG: a specific biomarker for neuromyelitis optica","volume":"22","author":"Weinshenker","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jneuroim.2012.09.010_bb0165","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:20:21Z","timestamp":1759047621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0165572812002834"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.09.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}